What are thrombosis risk and management considerations in COVID-19?
Publication Title
ACC Feature | Key Questions on COVID-19 and Cardiovascular Disease
Document Type
Article
Publication Date
4-22-2020
Keywords
cards; cards publication; 2019-nCoV
Abstract
Principal Guidance: The apparent increased thrombotic risk in COVID-19 patients is sufficient to recommend pharmacological VTE prophylaxis in all hospitalized patients unless contraindicated; D-dimer levels may be valuable for clinical monitoring, but there is currently no evidence supporting its use to guide anticoagulation intensity beyond clinical judgment; post-discharge VTE prophylaxis with a DOAC should be considered.
Area of Special Interest
Cardiovascular (Heart)
Specialty/Research Institute
Cardiology
Specialty/Research Institute
Infectious Diseases
